New leaders named to Vanderbilt-Ingram research programs
Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center's research programs.
Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center's research programs.
Human research will be more equitable, inclusive and stronger if the people who are participants in studies also help plan and guide the direction of those studies.
A study by Vanderbilt researchers has identified genomic alterations in early stage adenocarcinomas of the lung that may indicate whether the lesions develop into aggressive tumors.
Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign.
A new multisite study will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.
Travis Osterman, DO, MS, has been awarded a Microsoft Investigator Fellowship.
A five-year follow-up study of U.S. men who received prostate cancer treatment is creating a road map for future patients to clarify expectations and enable men to make informed choices about care.
Shari Barkin, MD, MSHS, division chief of General Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt, was honored recently with the 2019 Academic Pediatric Association (APA) Research Award.
Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.